|Title:||Methods for treating HCV|
|Abstract:|| This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.|
|Inventor(s):|| Ray; Adrian S. (Burlingame, CA), Link; John O. (San Francisco, CA), Oldach; David W. (Chapel Hill, NC), Delaney, IV; William E. (Foster City, CA), Mo; Hongmei (Palo Alto, CA), Yang; Cheng Yong (Foster City, CA) |
|Assignee:|| Gilead Pharmasset LLC (Foster City, CA) |
|Filing Date:||May 01, 2013|
|Claims:||1. A method of treating an HCV infection in a human, comprising administering to the human: 1) compound 10 having the structure: ##STR00075## or a pharmaceutically acceptable salt thereof and 2) compound 6 having the structure: ##STR00076## or a pharmaceutically acceptable salt thereof, wherein the method does not include administering interferon. |
2. The method of claim 1 wherein compound 10 and compound 6 are administered orally.
3. The method of claim 1 wherein ribavirin an interferon is not administered to the human.
4. The method of claim 1 further comprising administering ribavirin to the human.